Invention Grant
US07709625B2 Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy
失效
用于基因治疗的基因的骨髓干细胞来源的巨噬细胞递送的方法和组合物
- Patent Title: Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy
- Patent Title (中): 用于基因治疗的基因的骨髓干细胞来源的巨噬细胞递送的方法和组合物
-
Application No.: US11199465Application Date: 2005-08-08
-
Publication No.: US07709625B2Publication Date: 2010-05-04
- Inventor: Senlin Li , Robert A. Clark
- Applicant: Senlin Li , Robert A. Clark
- Applicant Address: US TX Austin
- Assignee: The Board of Regents of the University of Texas
- Current Assignee: The Board of Regents of the University of Texas
- Current Assignee Address: US TX Austin
- Agency: Myers Bigel Sibley & Sajovec P.A.
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/63 ; C12N15/00 ; C12N5/00 ; C12Q1/68

Abstract:
The present invention provides an isolated nucleic acid comprising a promoter operably linked to a nucleic acid encoding a peptide or protein and/or an RNA (e.g., antisense or ribozyme), wherein the promoter comprises elements that can include, but are not limited to, a) a myeloid specific promoter element comprising a core sequence GAGGAA; b) a myeloid specific promoter element comprising a core sequence AAGGAGAAG; c) a myeloid specific promoter element comprising a core sequence TTTCCAAA; d) a myeloid specific promoter element comprising a core sequence TGTGGTTGC; e) a myeloid specific promoter element comprising a core sequence TGAGTCA; f) a myeloid associated promoter element comprising a core sequence CCGCCC; and g) any combination of (a), (b), (c), (d), (e) and/or (f), any combination of multiples of (a), (b), (c), (d), (e) and/or (f), in any order and/or in any orientation (forward or reverse).
Public/Granted literature
- US20060018889A1 Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy Public/Granted day:2006-01-26
Information query